{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:05:26Z","timestamp":1790622326328,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:p>Major depression is one of the most common affective disorders caused by schizophrenia. The administration of <jats:italic toggle=\"yes\">N<\/jats:italic>-methyl-<jats:sc>d<\/jats:sc>-aspartate receptor antagonists, such as ketamine, can reproduce the negative and affective symptoms of this disorder in animals. Preclinical studies have shown that 5-HT<jats:sub>6<\/jats:sub> receptor (5-HT<jats:sub>6<\/jats:sub>R) agonists and antagonists have a considerable antipsychotic response. The aim of the present study was to evaluate the effect of an acute treatment with an agonist, E-6837, and an antagonist, SB-271046, of 5-HT<jats:sub>6<\/jats:sub>R on the immobility induced in mice by a subchronic ketamine regimen (5 days; 10\u2009mg\/kg\/day, intraperitoneal). Repeated ketamine administration alone increased the immobility time in the forced-swimming test and the tail-suspension test. E-6837 at 10 and 20\u2009mg\/kg caused a significant reduction of immobility in the tail-suspension test and forced-swimming test, respectively. Interestingly, SB-271046 (10\u2009mg\/kg) also elicited an antidepressant-like effect in both tests. The current findings suggest an important role for these 5-HT<jats:sub>6<\/jats:sub>R ligands as mood modulators. However, it is necessary to explore the physiological mechanisms involved in this process in greater detail.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000327","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T18:10:30Z","timestamp":1499883030000},"page":"582-585","source":"Crossref","is-referenced-by-count":22,"title":["Agonist E-6837 and antagonist SB-271046 of 5-HT6 receptors both reverse the depressive-like effect induced in mice by subchronic ketamine administration"],"prefix":"10.1097","volume":"28","author":[{"given":"Jos\u00e9 E.","family":"Su\u00e1rez-Santiago","sequence":"first","affiliation":[{"name":"Escuela Superior de Medicina, Instituto Polit\u00e9cnico Nacional, Mexico City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Briones-Aranda","sequence":"additional","affiliation":[{"name":"Faculty of Human Medicine, Autonomous University of Chiapas, Tuxtla Guti\u00e9rrez, Chiapas, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Espinosa-Raya","sequence":"additional","affiliation":[{"name":"Escuela Superior de Medicina, Instituto Polit\u00e9cnico Nacional, Mexico City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofir","family":"Picazo","sequence":"additional","affiliation":[{"name":"Escuela Superior de Medicina, Instituto Polit\u00e9cnico Nacional, Mexico City"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230910","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0166-4328(01)00235-2","article-title":"Enhancement of immobility induced by repeated phencyclidine injection: association with c-Fos protein in the mouse brain","volume":"124","author":"Abdel-Naby","year":"2001","journal-title":"Behav Brain Res"},{"key":"R2-20230910","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1590\/1516-4446-2013-1098","article-title":"Animal models as tools to study the pathophysiology of depression","volume":"35","author":"Abelaira","year":"2013","journal-title":"Rev Bras Psiquiatr"},{"key":"R3-20230910","first-page":"1","article-title":"Rapid antidepressant effect of ketamine correlates with astroglial plasticity in the hippocampus","volume":"14","author":"Ardalan","year":"2017","journal-title":"Br J Pharmacol"},{"key":"R4-20230910","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neuropharm.2015.03.032","article-title":"Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT6 receptors in the dorsal raphe nucleus","volume":"95","author":"Asaoka","year":"2015","journal-title":"Neuropharmacology"},{"key":"R5-20230910","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00213-010-1798-7","article-title":"Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats","volume":"213","author":"Carr","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"R6-20230910","first-page":"10A","article-title":"Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice","volume":"8","author":"Castagn\u00e9","year":"2011","journal-title":"Curr Protoc Neurosci"},{"key":"R7-20230910","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pnpbp.2012.04.018","article-title":"Ketamine-enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophrenia","volume":"38","author":"Chindo","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R8-20230910","first-page":"348","article-title":"Effects of Ketamine on resting-state EEG activity and their relationship to perceptual\/dissociative symptoms in healthy humans","volume":"27","author":"De la Salle","year":"2016","journal-title":"Front Pharmacol"},{"key":"R9-20230910","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0269881113512909","article-title":"Reviewing the ketamine model for schizophrenia","volume":"28","author":"Frohlich","year":"2014","journal-title":"J Psychopharmacol"},{"key":"R10-20230910","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.lfs.2009.01.019","article-title":"Procognitive 5-HT6 antagonists in the rat forced swimming test: potential therapeutic utility in mood disorders associated with \u2019Alzheimer\u2019s disease","volume":"10","author":"Hirano","year":"2009","journal-title":"Life Sci"},{"key":"R11-20230910","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00210-015-1141-2","article-title":"Antidepressant-like activity of EMD 386088, a 5-HT6 receptor partial agonist, following systemic acute and chronic administration to rats","volume":"388","author":"Jastrz\u0119bska-Wi\u0119sek","year":"2015","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R12-20230910","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pharep.2015.05.027","article-title":"Stimulation of the metabotropic glutamate (mGlu) 2 receptor attenuates the MK-801-induced increase in the immobility time in the forced swimming test in rats","volume":"68","author":"Kawaura","year":"2016","journal-title":"Pharmacol Rep"},{"key":"R13-20230910","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/bph.12509","article-title":"ADN-1184 a monoaminergic ligand with 5-HT(6\/7) receptor antagonist activity: pharmacological profile and potential therapeutic utility","volume":"171","author":"Ko\u0142aczkowski","year":"2014","journal-title":"Br J Pharmacol"},{"key":"R14-20230910","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/syn.10288","article-title":"5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex","volume":"51","author":"Lacroix","year":"2004","journal-title":"Synapse"},{"key":"R15-20230910","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1017\/S146114571100085X","article-title":"Mouse strain differences in phencyclidine-induced behavioural changes","volume":"15","author":"Mouri","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"R16-20230910","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fpsyt.2015.00013","article-title":"Schizophrenia and depression co-morbidity: what we have learned from animal models","volume":"6","author":"Samsom","year":"2015","journal-title":"Front Psychiatry"},{"key":"R17-20230910","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/sj.npp.1301503","article-title":"Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466","volume":"33","author":"Schechter","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"R19-20230910","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S1092852900021015","article-title":"Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia","volume":"12","author":"Stahl","year":"2007","journal-title":"CNS Spectr"},{"key":"R20-20230910","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"R21-20230910","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1523\/JNEUROSCI.3110-06.2007","article-title":"Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation","volume":"27","author":"Svenningsson","year":"2007","journal-title":"J Neurosci"},{"key":"R22-20230910","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbr.2016.06.041","article-title":"Repeated ketamine treatment induces sex-specific behavioral and neurochemical effects in mice","volume":"312","author":"Thelen","year":"2016","journal-title":"Behav Brain Res"},{"key":"R23-20230910","first-page":"240","article-title":"Depression and schizophrenia: cause, consequence or trans-diagnostic issue?","volume":"43","author":"Upthegrove","year":"2016","journal-title":"Schizophr Bull"},{"key":"R24-20230910","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.neuropharm.2007.01.007","article-title":"Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression","volume":"52","author":"Weso\u0142owska","year":"2007","journal-title":"Neuropharmacology"},{"key":"R25-20230910","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.neuroscience.2009.07.061","article-title":"Activation of the 5-HT(6) receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus","volume":"164","author":"West","year":"2009","journal-title":"Neuroscience"},{"key":"R26-20230910","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1476-5381.2012.02022.x","article-title":"5-HT(6) receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms","volume":"167","author":"Woods","year":"2012","journal-title":"Br J Pharmacol"},{"key":"R27-20230910","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuropharm.2016.07.014","article-title":"Activation and blockade of prelimbic 5-HT6 receptors produce different effects on depressive-like behaviors in unilateral 6-hydroxydopamine-induced Parkinson\u2019s rats","volume":"110","author":"Zhang","year":"2016","journal-title":"Neuropharmacology"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008877-201710000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T08:11:58Z","timestamp":1694333518000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201710000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000327","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}